Abstract
The neuroprotective properties of the novel glutamic acid derivative neiroglutam have been studied in vitro and in vivo. Neiroglutam demonstrated the protective action on 6-OH-dopamine neurotoxicity model <MI> in vitro, where free radical oxidation is a basic part of pathogenesis. In control rats, focal brain ischemia caused significant increase in thiobarbituric acid reactive species (TBARS) level and decrease in superoxide dismutase (SOD) enzyme activity. In two-year-old rats, preventive administration of the neiroglutam caused a significant reduction in the TBARS plasma concentration (34.5%, p < 0.05), increased SOD activity, and increased the time of acid-induced hemolysis of erythrocytes (40%, p < 0.05).
MeSH terms
-
Animals
-
Brain Ischemia / drug therapy*
-
Brain Ischemia / metabolism
-
Brain Ischemia / pathology
-
Cell Line, Tumor
-
Erythrocytes / drug effects
-
Free Radicals / antagonists & inhibitors*
-
Free Radicals / metabolism
-
Glutamic Acid / analogs & derivatives
-
Glutamic Acid / pharmacology*
-
Hemolysis / drug effects
-
Humans
-
Male
-
Neurons / cytology
-
Neurons / drug effects
-
Neurons / metabolism
-
Neuroprotective Agents / pharmacology*
-
Oxidation-Reduction
-
Oxidative Stress
-
Oxidopamine / antagonists & inhibitors
-
Oxidopamine / pharmacology
-
Rats
-
Superoxide Dismutase / metabolism
-
Thiobarbituric Acid Reactive Substances / analysis
Substances
-
Free Radicals
-
Neuroprotective Agents
-
Thiobarbituric Acid Reactive Substances
-
Glutamic Acid
-
Oxidopamine
-
Superoxide Dismutase